{"entity":{"type":"insider","cik":"0001730336","url":"/insider/0001730336","json_url":"/insider/0001730336.json","name":"Bruno Lawrence","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":2,"first":"2020-02-04","last":"2026-08-04","span_basis":"filed_date"},"name_variants":[{"name":"Bruno Lawrence","source":"filing","n_filings":2,"first_seen":"2020-02-04","last_seen":"2026-08-04"}],"transactions":[{"id":5944535,"accession":"0001193125-26-331852","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-331852","line_url":"/filing/0001193125-26-331852#line-1","is_derivative":false,"issuer_cik":"0001730336","issuer_name":"Core Laboratories Inc. /DE/","issuer_ticker":"CLB","issuer_name_source":null,"issuer_url":"/issuer/0001730336","owner_cik":"0001730336","owner_name":"Bruno Lawrence","owner_url":"/insider/0001730336","role":"Director, Officer (Chairman and CEO)","officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":10.78,"price_display":"10.78","price_state":"stated","total_value":53900.0,"total_display":"53,900.00","shares_owned_after":262438.0,"shares_owned_after_display":"262,438","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-31","filed_date":"2026-08-04","scope":"insider"},{"id":3294979,"accession":"0001209191-20-006188","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-006188","line_url":"/filing/0001209191-20-006188#line-3","is_derivative":false,"issuer_cik":"0001000229","issuer_name":"CORE LABORATORIES N V","issuer_ticker":"CLB","issuer_name_source":null,"issuer_url":"/issuer/0001000229","owner_cik":"0001730336","owner_name":"Bruno Lawrence","owner_url":"/insider/0001730336","role":"Director, Officer (President & COO)","officer_title":"President & COO","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":35000.0,"total_display":"35,000.00","shares_owned_after":8799.0,"shares_owned_after_display":"8,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-03","filed_date":"2020-02-04","scope":"insider"},{"id":3294974,"accession":"0001209191-20-006188","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-006188","line_url":"/filing/0001209191-20-006188#line-2","is_derivative":false,"issuer_cik":"0001000229","issuer_name":"CORE LABORATORIES N V","issuer_ticker":"CLB","issuer_name_source":null,"issuer_url":"/issuer/0001000229","owner_cik":"0001730336","owner_name":"Bruno Lawrence","owner_url":"/insider/0001730336","role":"Director, Officer (President & COO)","officer_title":"President & COO","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":34.979,"price_display":"34.98","price_state":"stated","total_value":34979.0,"total_display":"34,979.00","shares_owned_after":9799.0,"shares_owned_after_display":"9,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-03","filed_date":"2020-02-04","scope":"insider"},{"id":3294971,"accession":"0001209191-20-006188","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-006188","line_url":"/filing/0001209191-20-006188#line-1","is_derivative":false,"issuer_cik":"0001000229","issuer_name":"CORE LABORATORIES N V","issuer_ticker":"CLB","issuer_name_source":null,"issuer_url":"/issuer/0001000229","owner_cik":"0001730336","owner_name":"Bruno Lawrence","owner_url":"/insider/0001730336","role":"Director, Officer (President & COO)","officer_title":"President & COO","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":34.6,"price_display":"34.60","price_state":"stated","total_value":34600.0,"total_display":"34,600.00","shares_owned_after":10799.0,"shares_owned_after_display":"10,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-03","filed_date":"2020-02-04","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001958086","name":"Core Laboratories Inc. /DE/","url":"/issuer/0001958086","role":"Director, Officer (Chairman and CEO)","n_filings":1,"first_seen":"2026-08-04","last_seen":"2026-08-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001000229","name":"CORE LABORATORIES N V","url":"/issuer/0001000229","role":"Director, Officer (President & COO)","n_filings":1,"first_seen":"2020-02-04","last_seen":"2020-02-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001730336","retrieved_at":"2026-08-21T04:15:17+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}